RightEye Enters Into Agreement With MIT to Research Ocular Biomarker 'Signature' for Lyme Disease BETHESDA, Md., April 25, 2022 (GLOBE NEWSWIRE) -- RightEye, the world's leading eye-tracking biomarker company, has signed a research collaboration agreement with the Massachusetts Institute of...